259 related articles for article (PubMed ID: 35196917)
1. The tumor immune-microenvironment in gastric cancer.
Fang F; Zhang T; Li Q; Chen X; Jiang F; Shen X
Tumori; 2022 Dec; 108(6):541-551. PubMed ID: 35196917
[TBL] [Abstract][Full Text] [Related]
2. Tumor microenvironment in gastric cancers.
Oya Y; Hayakawa Y; Koike K
Cancer Sci; 2020 Aug; 111(8):2696-2707. PubMed ID: 32519436
[TBL] [Abstract][Full Text] [Related]
3. Tumor microenvironment-mediated immune tolerance in development and treatment of gastric cancer.
Liu Y; Li C; Lu Y; Liu C; Yang W
Front Immunol; 2022; 13():1016817. PubMed ID: 36341377
[TBL] [Abstract][Full Text] [Related]
4. Myeloid-derived suppressor cells: Roles in the tumor microenvironment and tumor radiotherapy.
Yin Z; Li C; Wang J; Xue L
Int J Cancer; 2019 Mar; 144(5):933-946. PubMed ID: 29992569
[TBL] [Abstract][Full Text] [Related]
5. Cross-talk between myeloid-derived suppressor cells (MDSC), macrophages, and dendritic cells enhances tumor-induced immune suppression.
Ostrand-Rosenberg S; Sinha P; Beury DW; Clements VK
Semin Cancer Biol; 2012 Aug; 22(4):275-81. PubMed ID: 22313874
[TBL] [Abstract][Full Text] [Related]
6. Cytokines Orchestrating the Natural Killer-Myeloid Cell Crosstalk in the Tumor Microenvironment: Implications for Natural Killer Cell-Based Cancer Immunotherapy.
Gaggero S; Witt K; Carlsten M; Mitra S
Front Immunol; 2020; 11():621225. PubMed ID: 33584718
[TBL] [Abstract][Full Text] [Related]
7. Hypoxia: a key player in antitumor immune response. A Review in the Theme: Cellular Responses to Hypoxia.
Noman MZ; Hasmim M; Messai Y; Terry S; Kieda C; Janji B; Chouaib S
Am J Physiol Cell Physiol; 2015 Nov; 309(9):C569-79. PubMed ID: 26310815
[TBL] [Abstract][Full Text] [Related]
8. Tumor Immune Microenvironment and Its Related miRNAs in Tumor Progression.
Xing Y; Ruan G; Ni H; Qin H; Chen S; Gu X; Shang J; Zhou Y; Tao X; Zheng L
Front Immunol; 2021; 12():624725. PubMed ID: 34084160
[TBL] [Abstract][Full Text] [Related]
9. Immunology and immunotherapy in gastric cancer.
Xu X; Chen J; Li W; Feng C; Liu Q; Gao W; He M
Clin Exp Med; 2023 Nov; 23(7):3189-3204. PubMed ID: 37322134
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic Approaches Targeting the Natural Killer-Myeloid Cell Axis in the Tumor Microenvironment.
Carnevalli LS; Ghadially H; Barry ST
Front Immunol; 2021; 12():633685. PubMed ID: 33953710
[TBL] [Abstract][Full Text] [Related]
11. Immunosuppressive cells in tumor immune escape and metastasis.
Liu Y; Cao X
J Mol Med (Berl); 2016 May; 94(5):509-22. PubMed ID: 26689709
[TBL] [Abstract][Full Text] [Related]
12. Role of lymphocytes, macrophages and immune receptors in suppression of tumor immunity.
Singh A; Anang V; Kumari K; Kottarath SK; Verma C
Prog Mol Biol Transl Sci; 2023; 194():269-310. PubMed ID: 36631195
[TBL] [Abstract][Full Text] [Related]
13. Dual Relationship Between Stromal Cells and Immune Cells in the Tumor Microenvironment.
Mun JY; Leem SH; Lee JH; Kim HS
Front Immunol; 2022; 13():864739. PubMed ID: 35464435
[TBL] [Abstract][Full Text] [Related]
14. Crosstalk between T lymphocyte and extracellular matrix in tumor microenvironment.
Lv D; Fei Y; Chen H; Wang J; Han W; Cui B; Feng Y; Zhang P; Chen J
Front Immunol; 2024; 15():1340702. PubMed ID: 38690275
[TBL] [Abstract][Full Text] [Related]
15. Notch Signaling in Myeloid Cells as a Regulator of Tumor Immune Responses.
Hossain F; Majumder S; Ucar DA; Rodriguez PC; Golde TE; Minter LM; Osborne BA; Miele L
Front Immunol; 2018; 9():1288. PubMed ID: 29915603
[TBL] [Abstract][Full Text] [Related]
16. Implications of NOVA1 suppression within the microenvironment of gastric cancer: association with immune cell dysregulation.
Kim EK; Yoon SO; Jung WY; Lee H; Kang Y; Jang YJ; Hong SW; Choi SH; Yang WI
Gastric Cancer; 2017 May; 20(3):438-447. PubMed ID: 27318497
[TBL] [Abstract][Full Text] [Related]
17. Cellular constituents of immune escape within the tumor microenvironment.
Kerkar SP; Restifo NP
Cancer Res; 2012 Jul; 72(13):3125-30. PubMed ID: 22721837
[TBL] [Abstract][Full Text] [Related]
18. Long Non-Coding RNAs in the Tumor Immune Microenvironment: Biological Properties and Therapeutic Potential.
Pi YN; Qi WC; Xia BR; Lou G; Jin WL
Front Immunol; 2021; 12():697083. PubMed ID: 34295338
[TBL] [Abstract][Full Text] [Related]
19. Immunotherapy Targeting Myeloid-Derived Suppressor Cells (MDSCs) in Tumor Microenvironment.
Gao X; Sui H; Zhao S; Gao X; Su Y; Qu P
Front Immunol; 2020; 11():585214. PubMed ID: 33613512
[TBL] [Abstract][Full Text] [Related]
20. Mesenchymal stromal cells (MSCs) and colorectal cancer: a troublesome twosome for the anti-tumour immune response?
O'Malley G; Heijltjes M; Houston AM; Rani S; Ritter T; Egan LJ; Ryan AE
Oncotarget; 2016 Sep; 7(37):60752-60774. PubMed ID: 27542276
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
